Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Ophthalmic company ISTA gained $0.82 (15%) to $6.33 on Monday after the
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury